(Q34464747)

2 August 2017

title

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain (English)

1 reference

multicenter clinical trial

2 August 2017

0 references

0 references

0 references

0 references

Joel Raskin

1

1 reference

2 August 2017

Yili L Pritchett

2

1 reference

2 August 2017

Fujun Wang

3

1 reference

2 August 2017

Deborah N D'Souza

4

1 reference

2 August 2017

Amy L Waninger

5

1 reference

2 August 2017

Smriti Iyengar

6

1 reference

2 August 2017

Joachim F Wernicke

7

1 reference

2 August 2017

publication date

1 September 2005

1 reference

2 August 2017

1 reference

2 August 2017

volume

6

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

346-356

1 reference

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

Prevention and treatment of the complications of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

Diabetic somatic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

Peripheral diabetic neuropathy: current concepts in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

Type I Error Rates from Mixed Effects Model Repeated Measures versus Fixed Effects Anova with Missing Values Imputed via Last Observation Carried Forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

Effects of duloxetine on painful physical symptoms associated with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2005.00061.X

10.1111/J.1526-4637.2005.00061.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference